O
JAZZ icon

Ossiam’s Jazz Pharmaceuticals JAZZ Stock Holding History

Ossiam’s Portfolio JAZZ Stock Details JAZZ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-2,195
Closed -$270K – 657
2023
Q4 		$270K Hold
2,195
– – ﹤0.01% 566
2023
Q3 		$284K Sell
2,195
-238
-10% -$31.7K 0.01% 566
2023
Q2 		$302K Buy
2,433
+1,386
+132% +$186K 0.01% 530
2023
Q1 		$153K Sell
1,047
-3,709
-78% -$549K ﹤0.01% 520
2022
Q4 		$758K Sell
4,756
-1,845
-28% -$270K 0.02% 310
2022
Q3 		$880K Buy
6,601
+2,577
+64% +$392K 0.03% 281
2022
Q2 		$628K Buy
+4,024
New +$619K 0.02% 278
2022
Q1 		– Sell
-523
Closed -$67K – 458
2021
Q4 		$67K Buy
+523
New +$68.7K ﹤0.01% 384
2021
Q2 		– Sell
-5,745
Closed -$944K – 463
2021
Q1 		$944K Buy
5,745
+937
+19% +$154K 0.03% 229
2020
Q4 		$794K Buy
4,808
+666
+16% +$99.2K 0.03% 209
2020
Q3 		$591K Buy
4,142
+513
+14% +$63.6K 0.02% 230
2020
Q2 		$400K Buy
+3,629
New +$401K 0.03% 260
2019
Q4 		– Sell
-106
Closed -$14K – 496
2019
Q3 		$14K Sell
106
-10
-9% -$1.34K ﹤0.01% 463
2019
Q2 		$17K Buy
+116
New +$15.6K ﹤0.01% 464

Other funds holding JAZZ

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
PCM
Polaris Capital Management Boston, Massachusetts $1.06B AUM 40.82% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $39.3B AUM 27.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ossiam's JAZZ Position: Q1 2024 in Review

Ossiam sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2024, closing a stake of 2,195 shares — an estimated $270K sold.

Ossiam first reported a position in JAZZ in Q2 2019 and held it in 14 quarters. The position peaked at $944K in Q1 2021. 481 funds tracked by Wall St. Rank hold JAZZ as of Q1 2024.

  • Ossiam reported no remaining Jazz Pharmaceuticals position as of Q1 2024 after selling out during the quarter.
  • Ossiam sold 2,195 Jazz Pharmaceuticals shares in Q1 2024, an estimated $270K.
  • Ossiam first reported a position in Jazz Pharmaceuticals in Q2 2019 and held it in 14 quarters.
  • Ossiam's Jazz Pharmaceuticals position peaked at $944K in Q1 2021.
  • 481 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2024.

Based on Ossiam's 13F filing for Q1 2024, filed 13 May 2024.